| Templin, Christian |
OCTandCAV, NCT02254668: Intracoronary Analysis of Cardiac Allograft Vasculopathy by Means of Optical Coherence Tomography |
|
|
| Recruiting | 4 | 278 | Europe | Protocol with Everolimus (Certican®), Randomizaiton by SecuTrial, Protocol with Mycophenolate mofetil (CellCept®) | University of Zurich, Novartis Pharmaceuticals | Intimal Proliferation, Immunosuppression | 02/23 | 02/23 | | |
| Stähli, Barbara E |
EXAMINE-CAD, NCT05294887: Randomized Trial to Examine a Differential Therapeutic Response in Symptomatic Patients With Non-obstructive Coronary Artery Disease |
|
|
| Recruiting | 4 | 132 | Europe | Bisoprolol, beta blocker, Diltiazem, Placebo | Charite University, Berlin, Germany, Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) | Coronary Microvascular Dysfunction, Microvascular Angina, Vasospasm, Coronary, Vasospastic Angina, Prinzmetal Angina, Coronary Artery Disease | 06/24 | 06/24 | | |
MATRIX-2, NCT05955365: Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation |
|
|
| Recruiting | 4 | 3010 | Europe | P2Y12 inhibitor, Aspirin, DOAC | Insel Gruppe AG, University Hospital Bern, Sahajanand Medical Technologies Limited | Percutaneous Coronary Intervention (PCI), Atrial Fibrillation (AF), Oral Anticoagulation, P2Y12 Inhibitor | 09/26 | 12/26 | | |
| Completed | N/A | 840 | Europe | Staged complete PCI, Immediate complete PCI, Synergy™ stent | University of Zurich | ST-elevation Myocardial Infarction, Multivessel Coronary Disease | 05/23 | 05/23 | | |
TAVI-PCI, NCT04310046: Optimal Timing of Transcatheter Aortic Valve Implantation and Percutaneous Coronary Intervention - The TAVI PCI Trial |
|
|
| Recruiting | N/A | 986 | Europe | PCI before TAVI, PCI after TAVI | University of Zurich | Aortic Stenosis, Coronary Artery Disease, TAVI, PCI | 07/26 | 07/31 | | |
| Active, not recruiting | N/A | 3326 | Europe, RoW | SELUTION SLR, DES | M.A. Med Alliance S.A. | Coronary Artery Disease | 08/25 | 07/30 | | |
IMPACTavi, NCT04976062: NIRS-IVUS to Improve Assessment of Coronary Artery Disease Severity in Patients Referred for Transcatheter Aortic Valve Implantation |
|
|
| Recruiting | N/A | 150 | Europe | Combined near-infrared spectroscopy and intravascular ultrasound imaging (NIRS-IVUS) | Deutsches Herzzentrum Muenchen, Infraredx Inc | Coronary Artery Disease, Aortic Stenosis, Severe | 12/24 | 12/24 | | |
| Recruiting | N/A | 60 | Europe | CONFIRM Rx implantable cardiac rhythm monitor (Abbott), Systematic etiologic work-up for underlying causes of MINOCA | Insel Gruppe AG, University Hospital Bern, University Hospital, Zürich, Bangerter-Rhyner Stiftung, Abbott | MINOCA, Atrial Fibrillation | 05/26 | 05/31 | | |
ULTRA-LM, NCT05650411: Ultrathin-strut Biodegradable Polymer Sirolimus-eluting Stents With P2Y12 Inhibitor-based Single Antiplatelet Therapy vs. Conventional DAPT for Unprotected Left Main Coronary Artery Disease (ULTIMATE-LM) |
|
|
| Not yet recruiting | N/A | 828 | Europe | LMCA PCI with Supraflex Cruz ultrathin-strut biodegradable polymer sirolimus-eluting stent (Sahajanand Medical Technologies Ltd., Surat, India)., P2Y12 inhibitor-based SAPT after short DAPT, Conventional DAPT | IGLESIAS Juan Fernando, University of Bern | Left Main Coronary Artery Stenosis | 05/27 | 05/30 | | |
| Bär, Sarah |
| Recruiting | N/A | 60 | Europe | CONFIRM Rx implantable cardiac rhythm monitor (Abbott), Systematic etiologic work-up for underlying causes of MINOCA | Insel Gruppe AG, University Hospital Bern, University Hospital, Zürich, Bangerter-Rhyner Stiftung, Abbott | MINOCA, Atrial Fibrillation | 05/26 | 05/31 | | |
